Inulin, a commonly used dietary fiber supplement, is
capable of
modulating the gut microbiome. Chronic inflammation resulting from
metabolic abnormalities and gut flora dysfunction plays a significant
role in the development of type 2 diabetes mellitus (T2DM). Our research
has demonstrated that inulin administration effectively reduced colonic
inflammation in T2DM mice by inducing changes in the gut microbiota
and increasing the concentration of butyric acid, which in turn modulated
the function of enteric glial cells (EGCs). Experiments conducted
on T2DM mice revealed that inulin administration led to an increase
in the Bacteroidetes/Firmicutes ratio and the concentration of butyric
acid in the colon. The anti-inflammatory effects of altered gastrointestinal
flora and its metabolites were further confirmed through fecal microbiota
transplantation. Butyric acid was found to inhibit the activation
of the κB inhibitor kinase β/nuclear factor κB pathway,
regulate the expression levels of interleukin-6 and tumor necrosis
factor-α, suppress the abnormal activation of EGCs, and prevent
the release of inflammatory factors by EGCs. Similar results were
observed in vitro experiments with butyric acid. Our findings demonstrate
that inulin, by influencing the intestinal flora, modifies the activity
of EGCs to effectively reduce colonic inflammation in T2DM mice.